Aspirin-free strategy versus standard term dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials

Eur J Prev Cardiol. 2021 Oct 13;28(12):e25-e28. doi: 10.1177/2047487320925623.

Authors

Mohammad Saud Khan¹, Abdelmoniem Moustafa¹, Abdullah Zoheb Azhar², Abdur Rahman Khan³, Sohail Ikram⁴

Affiliations

¹ Department of Medicine, The Miriam Hospital and Warren Alpert School of Brown University, USA.
² Department of Medicine, Metropolitan Hospital Center, USA.
³ Division of Cardiology, Massachusetts General Hospital, USA.
⁴ Division of Cardiovascular Medicine, University of Louisville School of Medicine, USA.

PMID: 32469617
DOI: 10.1177/2047487320925623

No abstract available

Publication types

Letter

MeSH terms

Aspirin / adverse effects
Drug Therapy, Combination
Dual Anti-Platelet Therapy / adverse effects
Humans
Percutaneous Coronary Intervention* / adverse effects
Platelet Aggregation Inhibitors* / adverse effects
Randomized Controlled Trials as Topic
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Aspirin